Carlos Alban
Senior Vice President, Abbott Laboratories.
Companies
- SolventumBoard member Apr 2, 2024 to now1
- SpringWorks Therapeutics, Inc.Board member Jul 15, 2022 to now2
- AbbVieEVP, Commercial Operations Dec 7, 2012 to Nov 18, 20203
- Abbott LaboratoriesSenior Vice President Oct 19, 2009 to Dec 4, 20124
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Abbott Laboratories ABT136,138 shares5$14.3M at $104.71Dec 1, 2012
Solventum SOLV8,947 shares6$764.4K at $85.44Apr 30, 2026- SpringWorks Therapeutics, Inc.0 shares7Jul 1, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 30, 2026Exercised options 3,403 shares of Solventum6
- Mar 27, 2026Exercised options 1,980 shares of Solventum8
- Jul 1, 2025Returned to company 28,861 shares of SpringWorks Therapeutics, Inc.7
- May 14, 2025Granted 10,060 shares of SpringWorks Therapeutics, Inc.9
- May 13, 2025Exercised options 3,564 shares of Solventum10
- May 16, 2024Granted 4,095 shares of SpringWorks Therapeutics, Inc.11
- May 24, 2023Granted 4,648 shares of SpringWorks Therapeutics, Inc.12
- Jul 14, 2022Granted 10,058 shares of SpringWorks Therapeutics, Inc.13
- Dec 1, 2012Granted 18,453 shares of Abbott Laboratories5
- Nov 16, 2012Gift 40,442 shares of Abbott Laboratories5
- Nov 16, 2012Gift 40,442 shares of Abbott Laboratories5
- Oct 15, 2012Shares withheld for tax 2,032 shares at $69.28 of Abbott Laboratories14
- Oct 15, 2012Granted 4,900 shares of Abbott Laboratories14
- Sep 25, 2012Sold 1,198 shares at $70.00 of Abbott Laboratories15
- Sep 25, 2012Exercised options 1,198 shares at $57.25 of Abbott Laboratories15
- Sep 20, 2012Sold 1,918 shares at $69.75 of Abbott Laboratories16
- Sep 20, 2012Exercised options 1,918 shares at $56.98 of Abbott Laboratories16
- Sep 13, 2012Sold 1,331 shares at $68.75 of Abbott Laboratories17
- Sep 13, 2012Exercised options 1,331 shares at $56.00 of Abbott Laboratories17
- Jul 30, 2012Sold 352 shares at $66.62 of Abbott Laboratories18
- Jul 27, 2012Sold 1,538 shares at $66.00 of Abbott Laboratories19
- Jul 27, 2012Sold 43,299 shares at $65.00 of Abbott Laboratories19
- Jul 27, 2012Exercised options 1,538 shares at $56.98 of Abbott Laboratories19
- Jul 27, 2012Exercised options 30,800 shares at $41.48 of Abbott Laboratories19
- Jul 27, 2012Exercised options 5,200 shares at $44.16 of Abbott Laboratories19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSolventum, Board member
- 2
- 3SEC EDGARAbbVie, EVP, Commercial Operations
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Mar 30, 2026
- 9SEC EDGARForm 4 filed May 15, 2025
- 10SEC EDGARForm 4 filed May 15, 2025
- 11SEC EDGARForm 4 filed May 17, 2024
- 12SEC EDGARForm 4 filed May 25, 2023
- 13SEC EDGARForm 4 filed Jul 15, 2022
- 14SEC EDGARForm 4 filed Oct 17, 2012
- 15SEC EDGARForm 4 filed Sep 27, 2012
- 16SEC EDGARForm 4 filed Sep 21, 2012
- 17SEC EDGARForm 4 filed Sep 17, 2012
- 18SEC EDGARForm 4 filed Aug 1, 2012
- 19SEC EDGARForm 4 filed Jul 30, 2012